Oncolytics Today Spring 2026
Published Date:
6 | Welcome Message A look at this issue of Oncolytics Today
112 | Scientific White Paper Leaders from Florida Cancer Specialists investigate the case for universal DPYD testing prior to 5-FU/capecitabine
115 | The UCSF Experience How a major health center transitioned immunotherapy administration to the outpatient setting
119 | New Reality in Cancer Care Just surviving cancer is only half the battle … treatment success does not always equate to full patient restoration
130 | Final Word NCODA Global Oncology & Haematology Congress expands NCODA’s reach and strengthens collaboration across borders
To Request The Oncolytics Today Media Kit / Rate Card, Contact: [email protected]
- Two issues in Spring (March) and Fall (October)
- Audience includes 10,000+ Oncology and Urology health professionals
- Print and digital formats available
- Multi-ad discounts available
Read Past Editions
Oncolytics Today
Oncolytics Today Fall 2025
A New Way to Treat Brain Cancer? A Phase 1 clinical trial explored the use of Rhenium (186Re) Obisbemeda (186RNL) for treating recurrent glioma, demonstrating its potential to deliver high radiation doses with minimal toxicity. The promising results, particularly in patients receiving higher doses, set the stage for further evaluation in Phase 2 trials.
October 3, 2025
Oncolytics Today
Oncolytics Today Spring 2025
A New Way to Treat Brain Cancer? A Phase 1 clinical trial explored the use of Rhenium (186Re) Obisbemeda (186RNL) for treating recurrent glioma, demonstrating its potential to deliver high radiation doses with minimal toxicity. The promising results, particularly in patients receiving higher doses, set the stage for further evaluation in Phase 2 trials.
April 21, 2025
Oncolytics Today
Oncolytics Today Fall 2024
THE BISPECIFIC ANTIBODY REVOLUTION: Breakthroughs in research have led to a host of new cellular therapies. In this issue of Oncolytics Today, we take a look at recently approved BsAbs as well as advances in tumor-infiltrating lymphocytes, antibody-drug conjugates and CAR-T therapy.
October 1, 2024
Oncolytics Today
Oncolytics Today Spring 2024
Filling the Diversity Gap in Cancer Care: Racial inequity in healthcare, particularly in oncology, has been well-documented. Bringing equity to charitable copay assistance and better communication across diverse healthcare teams offer opportunities to improve the situation.
April 1, 2024
Oncolytics Today
Oncolytics Today Fall 2023
Oncology Faces a Host of Rising Challenges: NCODA takes a hard look at the oncology drug shortage, the Stark Law’s impact on prescription mailing, alternative funding programs, the Inflation Reduction Act and 340B abuse.
October 1, 2023
Oncolytics Today
Oncolytics Today Spring 2023
Empower the medically integrated oncology pharmacy practice.
April 1, 2023